Samples From Leukemia Patients and Their Donors to Identify Specific Antigens
NCT02667093 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-03-04
Summary
The purpose of this project is to develop a process to identify highly personalized antigens that are uniquely expressed by the patient's own leukemia cells that can be used for cellular immune therapy.
Conditions
Sponsors & Collaborators
-
University of California, San Diego
collaborator OTHER -
PersImmune, Inc
lead INDUSTRY
Principal Investigators
-
Edward Ball, MD · University of California, San Diego
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
NCT00001432 ·Status: COMPLETED
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Stem Cell Transplantation for Patients With Cancers of the Blood
NCT00467961 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
NCT00275678 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
NCT00228631 ·Status: COMPLETED
-
Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
NCT00001405 ·Status: RECRUITING
-
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
NCT00075816 ·Status: COMPLETED ·Phase: PHASE3
-
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT
NCT03939585 ·Status: WITHDRAWN ·Phase: PHASE1
-
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome
NCT02330692 ·Status: UNKNOWN
-
Precision Medicine for Stem Cell Transplantation
NCT05567289 ·Status: RECRUITING
-
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT00295880 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543 ·Status: RECRUITING
-
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT03557749 ·Status: TERMINATED
-
An Evaluation of the Spectra Optia CMNC Collection Procedure
NCT02253160 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Cylex® ImmuKnow® Assay
NCT00569842 ·Status: COMPLETED
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
NCT06211166 ·Status: RECRUITING
-
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
NCT02663648 ·Status: WITHDRAWN
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®
NCT01901458 ·Status: COMPLETED ·Phase: NA
-
Screening for Hematology Branch Protocols
NCT00001620 ·Status: ENROLLING_BY_INVITATION
-
A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders
NCT00596999 ·Status: UNKNOWN